302 related articles for article (PubMed ID: 36140405)
21. A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation.
Zhong J; Rao X; Deiuliis J; Braunstein Z; Narula V; Hazey J; Mikami D; Needleman B; Satoskar AR; Rajagopalan S
Diabetes; 2013 Jan; 62(1):149-57. PubMed ID: 22936179
[TBL] [Abstract][Full Text] [Related]
22. The role of incretins in glucose homeostasis and diabetes treatment.
Kim W; Egan JM
Pharmacol Rev; 2008 Dec; 60(4):470-512. PubMed ID: 19074620
[TBL] [Abstract][Full Text] [Related]
23. Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes.
Zilleßen P; Celner J; Kretschmann A; Pfeifer A; Racké K; Mayer P
Sci Rep; 2016 Mar; 6():23074. PubMed ID: 26983599
[TBL] [Abstract][Full Text] [Related]
24. Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function.
Gong Q; Rajagopalan S; Zhong J
Int J Cardiol; 2015 Oct; 197():170-9. PubMed ID: 26142202
[TBL] [Abstract][Full Text] [Related]
25. The Multiple Biological Functions of Dipeptidyl Peptidase-4 in Bone Metabolism.
Yang Q; Fu B; Luo D; Wang H; Cao H; Chen X; Tian L; Yu X
Front Endocrinol (Lausanne); 2022; 13():856954. PubMed ID: 35586625
[TBL] [Abstract][Full Text] [Related]
26. Significance of circulatory DPP4 activity in metabolic diseases.
Nargis T; Chakrabarti P
IUBMB Life; 2018 Feb; 70(2):112-119. PubMed ID: 29331088
[TBL] [Abstract][Full Text] [Related]
27. Dipeptidyl peptidase-4 inhibitors and bone metabolism: is vitamin D the link?
Barchetta I; Cimini FA; Bloise D; Cavallo MG
Acta Diabetol; 2016 Oct; 53(5):839-44. PubMed ID: 27379733
[TBL] [Abstract][Full Text] [Related]
28. Role of glucose-dependent insulinotropic polypeptide in adipose tissue inflammation of dipeptidylpeptidase 4-deficient rats.
Ben-Shlomo S; Zvibel I; Varol C; Spektor L; Shlomai A; Santo EM; Halpern Z; Oren R; Fishman S
Obesity (Silver Spring); 2013 Nov; 21(11):2331-41. PubMed ID: 23408696
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD
J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639
[TBL] [Abstract][Full Text] [Related]
30. Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose.
Das SS; Hayashi H; Sato T; Yamada R; Hiratsuka M; Hirasawa N
Diabetes Metab Syndr Obes; 2014; 7():185-94. PubMed ID: 24920931
[TBL] [Abstract][Full Text] [Related]
31. Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients.
Sarkar J; Nargis T; Tantia O; Ghosh S; Chakrabarti P
Front Endocrinol (Lausanne); 2019; 10():505. PubMed ID: 31402899
[No Abstract] [Full Text] [Related]
32. Context-dependent effects of dipeptidyl peptidase 4 inhibitors.
Jackson EK
Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):83-90. PubMed ID: 27898522
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of DPP4 Is Associated with the AMPK/JAK2/STAT3 Pathway in Adipocytes Under Insulin Resistance Status and Liraglutide Intervention.
Cheng F; Yuan G; He J; Shao Y; Zhang J; Guo X
Diabetes Metab Syndr Obes; 2019; 12():2635-2644. PubMed ID: 31849507
[TBL] [Abstract][Full Text] [Related]
34. Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients.
Blaslov K; Bulum T; Duvnjak L
J Diabetes Complications; 2015 Apr; 29(3):390-4. PubMed ID: 25641023
[TBL] [Abstract][Full Text] [Related]
35. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors.
Mulvihill EE; Drucker DJ
Endocr Rev; 2014 Dec; 35(6):992-1019. PubMed ID: 25216328
[TBL] [Abstract][Full Text] [Related]
36. Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E372-9. PubMed ID: 21139073
[TBL] [Abstract][Full Text] [Related]
37. Dipeptidyl peptidase-4 and GLP-1 interplay in STC-1 and GLUTag cell lines.
Kamakura R; Raza GS; Prasannan A; Walkowiak J; Herzig KH
Peptides; 2020 Dec; 134():170419. PubMed ID: 32998057
[TBL] [Abstract][Full Text] [Related]
38. The regulatory role of DPP4 in atherosclerotic disease.
Duan L; Rao X; Xia C; Rajagopalan S; Zhong J
Cardiovasc Diabetol; 2017 Jun; 16(1):76. PubMed ID: 28619058
[TBL] [Abstract][Full Text] [Related]
39. DPP4 activity is related to body weight and central fat in postmenopausal women.
Siciliano PO; Godoy-Matos AF; Braga LDDC; Denise Pires Carvalho J; Corrêa JODA
Diabetes Metab Syndr; 2019; 13(5):3031-3034. PubMed ID: 30030159
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.
Ghorpade DS; Ozcan L; Zheng Z; Nicoloro SM; Shen Y; Chen E; Blüher M; Czech MP; Tabas I
Nature; 2018 Mar; 555(7698):673-677. PubMed ID: 29562231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
